Free Newsletters - Space - Defense - Environment - Energy - Solar - Nuclear
..
. 24/7 Space News .




SPACE MEDICINE
Fungal pathogen shows profound effects from spaceflight
by Richard Harth for The Biodesign Institute
Tempe AZ (SPX) Dec 19, 2013


Lead author Aurelie Crabbe, Cheryl Nickerson and Jennifer Barrila of the Biodesign Institute's Center for Infectious Diseases and Vaccinology (Photo: Anais Bon).

At Arizona State University's Biodesign Institute, Cheryl Nickerson and her team have been investigating the intriguing effects of spaceflight on microbial pathogens.

In a new paper appearing in the current issue of the journal PLOS ONE, the team reports their recent work examining spaceflight-induced responses in and infectious disease potential of the fungal pathogen, Candida albicans. Lead author Aurelie Crabbe joins a multi-institute collaborative research team in this study, which represents the first global gene expression profiling and phenotypic characterization of a fungal pathogen during spaceflight.

The new study reports the differential regulation of 452 genes in spaceflight-cultured C. albicans, compared to fungal cells cultured under otherwise identical ground-based conditions.

The expression of a wide variety of functionally diverse gene families was altered, including those regulating cell aggregation and budding, biofilm formation and resistance to pathogenesis-related stresses and antifungal drugs. In agreement with the gene expression data, C. albicans demonstrated enhanced cell aggregation and a differential budding pattern in response to growth under microgravity conditions.

"Our research has important medical implications for spaceflight safety and may also shed light on the as-yet poorly understood mechanisms of pathogen infection and disease trajectory, both in space and on earth," according to Crabbe.

Candida is a type of fungus-a eukaryotic microorganism. It is often found in soils and water and is ubiquitous in man-made environments, including the space shuttle and International Space Station. C. albicans is part of the normal flora of human beings, present on the skin, in the oral cavity, and in the gastrointestinal, urogenital and vaginal tracts.

Although it exists in 80 percent of the human population as an unobtrusive guest, C. albicans is an opportunistic pathogen, turning hostile under particular conditions. This process involves a transition from unicellular, yeast-like cells to a multicellular, filamentous and invasive form, triggered by specific environmental cues.

The pathogen in its transformed state poses a significant infectious disease risk. It is a particularly tenacious foe in immunocompromised individuals, like those undergoing treatment for AIDS, chemotherapy or bone marrow transplantation, and can also cause disease in normal individuals taking antibiotics. The unchecked fungus can cause superficial mucous membrane infections (such as thrush) but also sometimes leads to systemic candidiasis, a potentially lethal condition.

In the current study, fungal cell cultures of C. albicans were flown aboard the space shuttle Atlantis, on NASA Space Shuttle Mission STS-115. C. albicans is a considerable concern during spaceflight missions, as the harsh and rigorous environment encountered by astronauts weakens their immune system, leaving space voyagers especially vulnerable. Indeed, such infections are not uncommon among flight crews and are of grave concern during longer missions.

While the phenotypic changes induced by spaceflight were consistent with features associated with increased virulence, the spaceflight C. albicans cultures did not exhibit heightened virulence when mice were exposed through i.p. injection. Further research is required to conclusively determine if spaceflight alters C. albicans virulence. Of particular importance is to assess whether the compromised immune system of astronauts could influence their susceptibility to C. albicans infecti on.

The propensity of C. albicans to cause mucosal and deep tissue infections, coupled with the immunosuppressive condition characteristic of flight crew members, make a more thorough evaluation of virulence potential imperative.

The new research is the first to demonstrate global regulation induced by spaceflight in a eukaryotic pathogen-an essential step in disease-risk assessment. Results from this research will also serve to direct future spaceflight experiments and will allow scientists to further enhance their understanding of the response of microorganisms to the microgravity environment. The potential role of transcriptional regulators like Cap1, as well as other characteristics associated with a virulence phenotype are fertile ground for future study.

"This research serves as a springboard to inform ongoing spaceflight studies of Candida albicans, as well as to put our ground-based studies into context," says co-author Sheila Nielsen-Priess, of the Department of Immunology and Infectious Disease, Montana State University.

"The ultimate goal is to achieve a better understanding of how C. albicans causes infection, in space or here on Earth. Studying the yeast in the extreme environment of microgravity provides an additional window through which to view the cellular response and to better understand its behavior."

The Nickerson group has a long and productive track record of examining the effects of microgravity on various pathogenic microorganisms known to cause illness in humans. In previous studies, they sent a variety of pathogens for study aboard several different space shuttle missions to assess alterations in global gene and protein expression, morphology and virulence.

Among the more remarkable findings of this research are that pathogens globally alter their gene expression and disease-related properties during spaceflight culture in ways that cannot be observed during traditional experimental approaches, where the force of gravity can mask key responses.

One of the key factors influencing gene expression and physiological alterations to pathogenic cells in microgravity-both prokaryotic and eukaryotic-is a property known as fluid-shear. This refers to the level of abrasion caused by extracellular fluids flowing over cell surfaces.

Under microgravity conditions, fluid-shear is reduced, triggering changes in gene expression and associated phenotypic alterations. Such changes may in fact mimic conditions microbes encounter on earth, for example, regions in the human body where fluid-shear is similarly reduced, including in the gastrointestinal, urogenital and respiratory tracts.

Previously, the Nickerson team reported the landmark finding that spaceflight increased the virulence of Salmonella typhimurium, which was independently validated on two separate Shuttle missions. Their follow-up studies with NASA collaborators showed altered disease-related responses for Pseudomonas aeruginosa and a methicillin resistant Staphylococcus aureus (MRSA) strain when exposed to either spaceflight or spaceflight-analogue conditions produced on earth.

To simulate microgravity on earth, an apparatus known as a rotating wall vessel (RWV) bioreactor is used. This cylindrical device gently rotates cells, keeping them in suspension in low fluidic conditions relevant to those they encounter in spaceflight and in the human body during infection.

Nickerson and her colleagues demonstrated that a conserved protein known as Hfq serves as a master regulator that controls Salmonella and other bacterial pathogen responses to spaceflight and spaceflight analogue environments. The findings are significant, not only for understanding the mechanisms of bacterial gene regulation but also as a potential target for future therapies against pathogenic infection.

"I am pleased that our team's spaceflight research continues to provide compelling evidence of the value of the unique microgravity platform to unveil novel molecular and cellular responses in a variety of different human pathogens that are relevant to how they cause infection and disease in the body," says Nickerson. The results of this work have downstream implications for the health of both astronauts and the general public on Earth.

.


Related Links
Arizona State University's Biodesign Institute
Space Medicine Technology and Systems






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle




Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News





SPACE MEDICINE
Orbital samples with sight-saving potential
Houston TX (SPX) Dec 16, 2013
Those who travel to space are rewarded with a beautiful sight - planet Earth. But the effects of space travel on the human sense of sight aren't so beautiful. More than 30 percent of astronauts who returned from two-week space shuttle missions and 60 percent who spent six months aboard the International Space Station were diagnosed with eye problems. Two recent investigations examined mech ... read more


SPACE MEDICINE
China's Lunar Lander May Provide Additional Science for NASA Spacecraft

China plans to launch Chang'e-5 in 2017

Mining the moon is pie in the sky for China: experts

Ancient crater could hold clues about moon's mantle

SPACE MEDICINE
Opportunity Communications Remain Slow Due To Odyssey Issues

New Views of Mars from Sediment Mineralogy

NASA poised to launch Mars atmosphere probe

The Tough Task of Finding Fossils While Wearing a Spacesuit

SPACE MEDICINE
Asia's year in space triggers applause but also worry

NASA's network for talking to space missions nears 50th anniversary

IBM sees five tech-powered changes in next five years

European consortium space company to offer 'affordable' trips to space

SPACE MEDICINE
Deep space monitoring station abroad imperative

Chinese sci-fi writers laud moon landing

China deploys 'Jade Rabbit' rover on moon

The Dragon Has Landed

SPACE MEDICINE
NASA rigs up snorkel in spacesuit after risky water leak

NASA postpones cargo mission for space station repairs

Altitude of International Space Station raised

NASA mulls spacewalks to fix space station

SPACE MEDICINE
Gaia secured inside fairing

India to decide December 27 on GSAT-14 launch date

Arianespace orders 18 rockets for 2 bn euros

Iran sends second monkey into space

SPACE MEDICINE
Gaia Mission Could Help Map Exoplanets

First detection of a predicted unseen exoplanet

Astronomers solve temperature mystery of planetary atmospheres

Nearby failed stars may harbor planet

SPACE MEDICINE
MU Researchers Develop Advanced Three-Dimensional "Force Microscope"

'Approximate' computers could do tasks not requiring exact answers

Inertial Sensor Head shaken but not disturbed

Programming smart molecules




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement